H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer
(Q36021781)
scientific article
scientific article
Language:
Current Data About
H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer